chrisvoncsefalvay/vaers-outcomes huggingface dataset:
High temperatures; Head pain; The initial case was missing the following minimum criteria: the reporter cannot be identified for direct/private contact (internet source). Upon receipt of follow-up information on (08Oct2021), this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (reporter's father) of an unspecified age that received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced high temperatures on an unspecified date with outcome of unknown, head pain on an unspecified date with outcome of unknown. Seriousness criteria of the events was hospitalization. The patient underwent lab tests and procedures which included blood test: unknown results, body temperature: high (really high temperatures), stomach scan: unknown results, x-ray: unknown results. Therapeutic measures were taken as a result of high temperatures, head pain. The clinical course was reported as follows: "Hi, my name is withheld and I have a question about the vaccine. Over the last few months, my father is receiving really high temperatures and head pain after taking your Covid-19 vaccine. The GP doctor couldn't help him, except give him antibiotics which have not helped. He has been admitted to hospital last week and had several tests done(lung x-ray, stomach x-ray, blood tests etc.) but they cannot find the cause. Do you know of any medicine or cure that could help him? Could you send this message to who can help?"  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
MULTIPLE NOSE BLEEDS; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a 20 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced chills. On 29-MAR-2021, the subject experienced headache. On 03-APR-2021, the subject experienced multiple nose bleeds. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and headache on 31-MAR-2021, and had not recovered from multiple nose bleeds. This report was non-serious.; Sender's Comments: V0: As per standard procedure , comment is not required for non-serious case
At site of injection: skin is warm; arm is slightly tender to the touch; slight redness; slight itching  I experienced similar adverse events 2 days following injection that lasted approximately 36 hours and subsided.  It reappeared on 2/28/2021 and I was not able to note via v-safe.
Initial and follow up information has been received from a Registered Nurse concerning a white female patient who on the morning of 10-Aug-2006 was vaccinated IM with her first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast), lot #653650/0702F, and experienced flu-like symptoms. Concomitant medication included doxycline. No medical attention was sought. Within a day or two, the patient recovered. Additional information has been requested. Follow up information indicated that the patient received her second dose of GARDASIL and had no adverse experience. Additional information is not expected.
pt recv vax & during noc devel chills, h/a, lt eye pain, dizziness, sl fever, muscle aches & pains;20SEP95 devel huge, red rash & swollen area @ inj site described as hive-like;this local rxn noted by MD 21SEP95;
Information has been received from a physician concerning a 7 year old female who in approximately 2001 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and on approximately May-2007 was vaccinated with another dose of varicella virus vaccine live (Oka/Merck). On approximately 18-JUL-2007, the patient experienced fewer than 50 lesions after receiving the vaccine. The lesions were concentrated on the trunk and back, some were on the extremities. No lesions on the face. Unspecified medical treatment was sought. No product quality complaint. Additional information has been requested.
(numbness) in hand (numbness) in hand/ facial (numbness)/ a little bit of numbness in right hip; I started with mild symptoms and then they got progressively worse; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a physician and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (I started with mild symptoms and then they got progressively worse) and HYPOAESTHESIA ((numbness) in hand (numbness) in hand/ facial (numbness)/ a little bit of numbness in right hip) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (I started with mild symptoms and then they got progressively worse) and HYPOAESTHESIA ((numbness) in hand (numbness) in hand/ facial (numbness)/ a little bit of numbness in right hip). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (I started with mild symptoms and then they got progressively worse) and HYPOAESTHESIA ((numbness) in hand (numbness) in hand/ facial (numbness)/ a little bit of numbness in right hip) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
rash with raised bumps and redness; rash with raised bumps and redness; Facial irritation; Swelling of eyelids and area underneath eye brows; Itchiness where rash is; Irritation of gums; This is a spontaneous report from a contactable nurse.  A 58-years-old female patient (not pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via intramuscularly, administered in left arm on 15Feb2021 at 14:30 as single dose for covid-19 immunization. Medical history and concomitant medications were not reported. No Known allergies. She received first dose intramuscularly administered in left arm on 25Jan2021, at 02:30 pm, as single dose for covid-19 immunization. No other vaccine in four weeks. No other medications in two weeks. No Covid prior vaccination. No Covid tested post vaccination. On 15Feb2021 at 08:00 pm, she had Facial irritation and rash with raised bumps and redness. Swelling of eyelids and area underneath eyebrows. Itchiness where rash is present. Irritation of gums resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken of hydrocortisone cream to face. All events were assessed as non-serious with outcome of not recovered.  Information on the lot/batch number has been requested.
Shortness of breath and dizziness with normal activity and at rest Persistent dry cough Recurring rapid heartbeat, weighty feeling in chest Fatigue. Needing to rest every few minutes Bubbling feeling/sound in upper chest
TREATED BY PA 3 HRS AFTER INJECTION C SOB, PUFFY, CHILLS, SWOLLEN EYES, TIGHT THROAT, & FLUSHED. RX BENADRYL PO ONLY KEPT FOR 2-3 HRS FOR OBSERVATION. PATIENT HAS MANY ALLERGIES BUT NON TO NEOMYCIN, GELATIN.
Fever, aches, pains all over and chills. Pain, redness and swelling below injection site. All gone by 03/18/19.
Got shingles after 3 months side effects of vaccination/ Suspected vaccination failure; shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient got shingles after 3 months side effects of vaccination. This case was considered as suspected vaccination failure, since the details regarding completion of primary vaccination schedule, time to onset, and laboratory test confirming shingles were not provided.
Patient complained of left arm numbness and tingling stating "heavyness" as well .  Patient evaluated by EMS on site, HR:70's, BP:127/81. Patient was advised by EMS  transport to hospital. Pt refused. Pt educated by EMS to seek medical attention if symtoms persist or worsen.
01/10/22: RN, NC, ST, EAR PAIN, HA, COUGH, NAUSEA, BODY ACHES
It starts with light stomach ache and nausea, as time progresses (avg 30-90) mins the ache become cramps and spasms, some mild but about half have developed to severe needed to bee seen in ER.  Most spike fevers from 99.6 to 102.3.   vomiting usually happens around 90 min mark but not always.  After vomiting, then I continue to have Aches and spasms but begin to have the chills, even being wrapped in blankets I just cant seam to stay warm.   ER visit dates over last year:  @local Hospital ER  - 1/19/21; 3/7/21;  6/9/21;  7/14/21 (PCM visit); 8/18/21; 12/15/21(covid clinic) ER Visits to regional Hospital ER - 9/28/21; 1/14/22; 1/22/22.  I have had many more just not as painful that i did not go to ER. If needed I can submit Leave days taken from work due to this that I did not go to ER.  Since this first event i have continued to have them even up to last week (3/17) small event and (3/18) ER visit event.  With all my conditions, I have never had this very specific problem, which continues to happen in recent weeks,  before receiving the vaccine in Jan '21, and I hesitated submission of this as the professionals I have seen are not sure its vaccine related but after all the ER visits, PCM visits, Gastrointestinal Providers i see for Transplant and other issues they have no other explanation.
Pain at the injection site, fever (101.8), chills, muscle aches, headache.
Hives on face, neck, chest, both arms, right 5th finger, back and left foot with severe itching that began on face within 2 hours of injection and continued to multiply for 36 hours then started fading at 48 hours
Fever, headache, swelling around injection site (arm/neck/shoulder), nausea, brain fog
Localize reaction to right arm measured 5MM x 4MM, redness, swelling, warm to touch and painful 7/10. Pain is moving to lymph nodes underarmto right breast.
No treatments initially. Big chills in the evening of March 20 and difficulty breathing, 100.7 F fever by morning, inability to even sit on March 21 so I stayed mostly in bed, nausea, headache, sore throat, altered taste (things tasted bitter and as chalk), strong body aches. I  understand that the fever was not high, so my extreme weakness and exhaustion were not really related to the fever. Fever subsided by March 22, but numbness on the whole  left side of head and body appeared  for about 2 hours in the evening - unpleasant and scary, but I did not seek intervention. Headache and nausea on March 23 and 24. Total inability to sleep on the night of March 23/24 (stabbing headache and nausea contributed to a lot of anxiety). Finally took Xanax in the morning of March 24, so I finally slept between 7:30 and 10:30am. I am writing this at 3:30 pm on March 24. I am much better compared with March 21, but still with a significant headache and some nausea.   I had Covid-19 in the first half of November. Post-vaccine symptoms were similar to my covid symptoms, but quick. In December I got post-covid a-fib and was diagnosed with heart failure. Improved on medication, awaiting heart ablation in May 2021. I am concerned that with the strong reaction I felt  after the first dose, my reaction after the second dose may be even worse than that on March 21.
No antibodies after both doses; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (No antibodies after both doses) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (No antibodies after both doses). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (No antibodies after both doses) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: other (Negative) No antibodies after both doses.         No concomitant medications were reported.  No treatment information was provided.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. On multiple unknown dates, the patients were vaccinated with improperly stored VARIVAX (Merck) [Lot# L021211; Expiry date: 10-JUN-2017, Lot# L026407; 15-JUL-2017, Lot# L027287; 21-JUL-2017]. No adverse effect were reported. The nurse also inquired about the stability of M-M-R II; however, M-M-R II did not undergo a temperature excursion. This case is one of two reports from the same reporter. Additional information has been requested.
The following started the morning after the shot:    Achy,  no desire for food,  felt like I had a bad case of the flu, very tired and wanted to sleep all the time. The second day was the same, except that my Blood Pressure went up, and remains up.    It currently( Day 3) registers at    153/99, with a pulse of 101.
Pt c/o headache, muscle weakness, anxiety, flushing/sweating.  Pt indicates that they have a hx of adverse rxn reported w/ first vaccine dose but no VAERS was submitted by clinic staff at that time.  Clinical review cleared patient for second dose.  Pt assisted to bed. Abnormal vitals.  BP 251/91 (133), HR 82, RR 21 -- > 237/84 (120), 70, 17.  Pt denies hx of HTN, NKA.  Physician  advised patient to go to urgent care d/t elevated BP; pt verbalized understanding.  After 5 mins pt denies and HA, verbalizes feeling calm, muscle weakness resolved.  Pt ambulating w/o c/o dizziness.  Patient taken to Urgent Care/ER by private car.
She was told she has asthma but she does not feel she has it. She never had problems with asthma. She takes Dimetapp every night. She tried Tessalon perles but they did not help. She had unremarkable CXR. Trelegy but stopped since she did not think it helped. She stopped the albuterol because she thought it caused her tongue swelling but she now knows it is from the COVID vaccine.  She developed tongue numbness 3 days after the first shot and it lasted for 2-3 days. After the second dose, she developed tongue numbness and over right side of face. She also developed swollen gland on right side of her neck which is tender. It is smaller now and pain is intermittent.
Pt recv vax on unknown day; post vax pt exp fever, flu-like sx, swelling/red/itching/ warm vax site
Hepatitis B and HPV vaccine trasported to clinic in portable cooler. A vaccine excursion occurred with the portable cooler. The temperature on the portable cooler went out of range based on Engerix- B and manufacturer recommendations. The portable cooler reconditioned and Hepatitis B vaccine admistered to patient. Manufacturer conatcted by representative. Per the Health Department they were advised by GlaxoSmithKline  that the Hepatitis B vaccine was not viable and the patient needed to be revaccinated.
Presented to ED w c/o SOB, cough, & weakness x 3 days; tx as COVID PUI; tx w/steroids, remdesivir, abx & O2; weaned to RA for dc.
This initial spontaneous report was received from a nurse referring to multiple unspecified patients of unknown ages and genders. There was no pertinent medical history, concomitant medications or drug allergies/drug reactions described. On unspecified dates, the patients were administered improperly stored doses of RECOMBIVAX HB, injection (dose, route, anatomical location, lot # and expiration date were not reported). The nurse was not sure what specific vaccines were given, date of administration or what patients. No adverse effects were reported and a product quality complaint (PQC) was not involved. It was unknown if the patients sought medical attention. This is one of several reports received from the same reporter.  Additional information has been requested.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced 15 lesions/papules and a rash from neck to abdomen.
Information has been received from a certified medical assistant concerning a 29 year old female who on 25-SEP-2008 was vaccinated with a first dose of GARDASIL. The patient developed high blood pressure. The patient had always had normal blood pressure. Her blood pressure on 02-OCT-2008 was 148/88 and on 06-JAN-2009 it was 158/98. The patient sought unspecified medical attention. The patient's outcome is unknown. Follow up information received on 14-SEP-2009 from a physician indicated that the patient was a 28 year old female with no medical history, allergies or illness at the time of vaccination; it was also reported that the patient did not experience any adverse events following prior vaccinations. On 25-SEP-2008 at 10:15 was vaccinated with the first dose of GARDASIL (lot # 661764/0650X), intramuscularly. The patient received a second dose of GARDASIL (lot # 661764/0650X), intramuscularly on 20-NOV-2008 at 10:00. In October 2008, after the 2 doses of GARDASIL the patient developed high blood pressure. The patient was treated with hypertensive medication. The patient had an electrocardiogram done. At the time of this report the patient had not recovered. High blood pressure was considered to be an other important medical event. No further information is available.   9/30/09 Received PCP medical records of 6/30/09-  Records reveal patient was new patient to practice on 6/30 for essential hypertension management & had palpitations, microscopic hematuria, migraines, iron def anemia & acne.  Work up had been done be another MD.  Exam revealed xanthelasma.  BCPs had been d/c for 1 wk.  Advised against restarting & was also advised to d/c all meds due to probable drug induced HTN.  RTC 8/6/09 w/fever, cold s/s, enlarged & tender cervical lymph nodes.  Dx w/chronic tonsillitis & adnoiditis, dehydration.  Tx w/oral antibiotics.  Did not improve & RTC 8/13/09 w/wheezing & SOB.  Dx w/acute bronchitis.  Tx w/steroids, nebs, continued antibiotics & cough syrup.  RTC 9/10 w/continued HTN, restarted on anti-HTN meds & low dose ASA.  No further records available.
Side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
pt admitted to Hospice with anoxic brain injury; GIP agitation pt; pt had a positive COVID test on 12/23/21 Medical Center, after an asthma attack; hx of uncontrolled asthma, substance abuse, prior overdose, and seizures; poorly unresponsive; pt passed away in the hospice facility
HIGH FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 13-MAR-2021. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
On 07/23/2021 I started experiencing the symptoms of a cold, I had nasal drip, congestion, fever. My maximum fever on Friday evening was 100.5. I also felt tired. Given that I have been planning to fly out of state on Monday I decided that it would be wisest to get tested. I went to urgent care and described my symptoms and asked for a Covid test. I was offered a rapid antigen test which was positive. Then a PCR test which was positive as well. I was advised to isolate at home to take some vitamins, vitamin C and D and zinc. To take antipyretics as necessary and to report back if my symptoms worsen including difficulty breathing, faintness or signs of potential blood clots.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with M-M-R II, injection (route, dose, lot number and expiration date not provided). The reporter stated that an unspecified office called and asked for stability information for MMR II. The reporter stated that the MMR II exposed to 68 Fahrenheit degree for 15 hours and was administered to a patient. No adverse effects were reported. Additional information has been requested.
Pain present when sleeping and when playing racquetball approximately 0.5 inches distal to the acromion process.  Pain is focal and does not spread. Pain is not "achy." Pain may have started the day after vaccination and persists (24 days later) only when sleeping or "with activity."  Pain subsides when activity is stopped or when he is done rolling over while in bed. Pt has been encouraged to use OTC anti-inflammatory medications and heat applications; pt states he has not tried these.  Pt is encouraged to see his health care provide; pt states he has not scheduled an appointment to see his PCP.